Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug


By Teddy Rosenbluth from NYT Health https://ift.tt/1vzJGj0
your-feed-science, Appointments and Executive Changes, Drugs (Pharmaceuticals), Clinical Trials, Alzheimer's Disease, Falsification of Data, Research, Academic and Scientific Journals, Securities and Commodities Violations
Previous Post Next Post

Contact Form